Cabusas, Riza May .
HRN: 26-63-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/01/2025
CEFUROXIME 500MG (TAB)
02/02/2025
02/09/2025
PO
500mg
BID
S/P EL, Salpingectomy Right
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes